BESPOKE EXTRACTS, INC.

BSPK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Operating Activities
Net Income $-1.0M $-1.5M $-4.1M $-965.6K $-4.6M $2.6M $-7.6M $-6.7M
Depreciation & Amortization
Depreciation $9.6K $9.0K
Amortization $3.2K $2.8K $3.3K $3.3K $1.7K
Stock-Based Compensation $197.5K $380.4K $3.0M $-1.4M $6.5M $6.3M
Net Cash from Operating Activities $-289.8K $-415.2K $-798.1K $-1.0M $-465.2K $-492.7K $-747.7K $-422.1K
Investing Activities
Capital Expenditures $600.0K $7.2K $2.7K
Business Acquisitions
Net Cash from Investing Activities $-88.0K $-5.0K $90.0K $24.8K
Financing Activities
Dividends Paid
Stock Repurchases $27.5K
Net Cash from Financing Activities $343.5K $397.4K $762.2K $930.5K $581.5K $423.3K $650.3K $484.6K
Net Change in Cash $-115.4K $116.3K $-69.4K $-7.4K $87.3K
Free Cash Flow $-889.8K $-805.3K $-1.0M
← Newer Page 1 of 2 Older →